Cancer survivorship and the right to be forgotten are reshaping underwriting evidence rules for life and health reinsurance. Learn how treaties adapt when cancer history is legally removed from risk assessment.
Consent, provenance and health data have become the compliance bottleneck in life reinsurance. Learn how ceded re managers can build consent tracking frameworks that keep health data flowing lawfully and auditably.
Death-claim identity verification must balance fraud prevention with fast payment to families. Learn how reinsurers can verify identities accurately, reduce false positives, and settle legitimate claims without unnecessary delays.
Early-onset cancer is shifting incidence curves younger, challenging life and critical illness reinsurance pricing assumptions. Learn how treaty underwriters can adapt their surveillance and repricing approach.
EHR completeness vs. claims data is a critical question for life reinsurers when underwriting signals conflict. Learn how data provenance and reconciliation frameworks determine which source to trust for pricing and risk selection.
Long COVID creates claims that develop slowly and disrupt reserving patterns. Learn how health reinsurers can track these claims, adjust development triangles, and strengthen IBNR estimates for post-COVID portfolios.
Neurodivergence and fair underwriting require reinsurers to build an evidence trail as diagnostic norms evolve. Learn how chief medical officers can design underwriting guidelines that are fair, current, and auditable.